The characterization of the key SLK phosphorylation sites and regulation of catalytic activity may also provide novel targets for design of drugs [27,55], which may be useful in the treatment of acute kidney injury, glomerulonephritis, wound healing, cancer, and other diseases. The gene discussed is SLK; the disease is glomerulonephritis.